Thallion Pharmaceuticals Inc. Announces First Patient Enrolled In High Dose Cohort of Phase II SHIGATEC Trial
5/31/2011 1:08:20 PM
More...
|
Thallion Pharmaceuticals Inc.'s Phase II SHIGATEC Trial Proceeds to High Dose Cohort
5/16/2011 11:17:35 AM
More...
|
Thallion Pharmaceuticals Inc. and LFB Biotechnologies Initiate Phase II SHIGATEC Trial
11/29/2010 9:51:57 AM
More...
|
Thallion Pharmaceuticals Inc. Announces 2010 Third Quarter Results
10/13/2010 9:34:41 AM
More...
|
Thallion Pharmaceuticals Inc. Announces 2010 Second Quarter Results
7/13/2010 9:52:43 AM
More...
|
Thallion Pharmaceuticals Inc. Eliminates Long-Term Lease Obligation
6/24/2010 9:20:00 AM
More...
|
Thallion Pharmaceuticals Inc. to Pay C$2.4 Million to Shorten Lease Obligation; to Cancel Remaining 6 Years of 15-Year Lease
6/24/2010 6:27:06 AM
More...
|
Thallion Pharmaceuticals Inc. Receives Arbitration Decision on TLN-232 License Agreement
6/16/2010 9:09:54 AM
More...
|
Thallion Pharmaceuticals Inc. Announces 2010 First Quarter Results
4/13/2010 11:26:42 AM
More...
|
Thallion Pharmaceuticals Inc. Announces 2009 Year End Results
2/24/2010 10:45:35 AM
More...
|
|